Lactoferrin and cancer in different cancer models

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 3, 2011, Pages 1080-1088

  Gibbons, Jessica A ^a   Kanwar, Rupinder K ^a   Kanwar, Jagat R ^a  

^a Institute for Technology and Research Innovation   (Australia)

Author keywords

3D models; Cancer; Lactoferrin; Review

Indexed keywords

AZOXYMETHANE; CASPASE 3; CASPASE 8; CASPASE 9; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; LACTOFERRIN; PLACEBO;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; BLADDER CANCER; BREAST CANCER; CANCER CELL CULTURE; CANCER MODEL; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CHEMICAL STRUCTURE; COLON ADENOMA; COLON CANCER; COLORECTAL CANCER; COLORECTAL POLYP; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG CYTOTOXICITY; ENZYME ACTIVATION; ESOPHAGUS CANCER; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; IRON BINDING CAPACITY; LEWIS CARCINOMA; LUNG CANCER; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; LYMPHOMA; MACROPHAGE; MELANOMA; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PH; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; THERAPY EFFECT; ANIMAL; BIOLOGICAL MODEL; BLOOD CELL; CATTLE; CHEMISTRY; CULTURE TECHNIQUE; DOG; DRUG EFFECT; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; METHODOLOGY; MOUSE; NEOPLASM; ORAL DRUG ADMINISTRATION; RAT; REVIEW;

BOVINAE;

ADMINISTRATION, ORAL; ANIMALS; APOPTOSIS; BLOOD CELLS; CATTLE; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; DOGS; HUMANS; IMMUNITY, INNATE; LACTOFERRIN; MICE; MODELS, BIOLOGICAL; NEOPLASMS; RATS;

EID: 80053105748     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Iigo, M., D. B. Alexander, N. Long, J. Xu, K. Fukamachi, M. Futakuchi, M. Takase & H. Tsuda: Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine. Biochimie, 91, 86-101 (2009)
2. Tomita, M., H. Wakabayashi, K. Shin, K. Yamauchi, T. Yaeshima & K. Iwatsuki: Twenty-five years of research on bovine lactoferrin applications. Biochimie, 91, 52-7 (2009)
3. Tsuda, H., Y. Ohshima, H. Nomoto, K. Fujita, E. Matsuda, M. Iigo, N. Takasuka & M. A. Moore: Cancer prevention by natural compounds. Drug Metab Pharmacokinet, 19, 245-63 (2004)
4. Mulder, A. M., P. A. Connellan, C. J. Oliver, C. A. Morris & L. M. Stevenson: Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males. Nutr Res, 28, 583-9 (2008)
5. Gupta, I., Sehgal, R, Kanwar, RK, Sehgal, A and Kanwar, JR.: Recent Advances of Metal Binding Protein Lactoferrin as an Anti-Microbial Agent Current Bioactive Compounds, 5, 226-233 (2009)
6. Mistry, N., P. Drobni, J. Naslund, V. G. Sunkari, H. Jenssen & M. Evander: The anti-papillomavirus activity of human and bovine lactoferricin. Antiviral Res, 75, 258-65 (2007) (Pubitemid 46898653)
7. Baker, E. N. & H. M. Baker: A structural framework for understanding the multifunctional character of lactoferrin. Biochimie, 91, 3-10 (2009)
8. Baker, H. M. & E. N. Baker: Lactoferrin and iron: structural and dynamic aspects of binding and release. Biometals, 17, 209-16 (2004) (Pubitemid 38987139)
9. Baker, E. N. & H. M. Baker: Molecular structure, binding properties and dynamics of lactoferrin. Cell Mol Life Sci, 62, 2531-9 (2005) (Pubitemid 41721228)
10. Teng, C. T.: Factors regulating lactoferrin gene expression. Biochem Cell Biol, 84, 263-7 (2006) (Pubitemid 44341299)
11. Thotathil, Z. & M. B. Jameson: Early experience with novel immunomodulators for cancer treatment. Expert Opin Investig Drugs, 16, 1391-403 (2007) (Pubitemid 47491409)
12. Kuhara, T., K. Yamauchi, Y. Tamura & H. Okamura: Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in thesmall intestine. J Interferon Cytokine Res, 26, 489-99 (2006) (Pubitemid 44061089)
13. Takakura, N., H. Wakabayashi, K. Yamauchi & M. Takase: Influences of orally administered lactoferrin on IFN-gamma and IL-10 production by intestinal intraepithelial lymphocytes and mesenteric lymph-node cells. Biochem Cell Biol, 84, 363-8 (2006) (Pubitemid 44341312)
14. Freiburghaus, C., B. Janicke, H. Lindmark-Mansson, S. M. Oredsson & M. A. Paulsson: Lactoferricin treatment decreases the rate of cell proliferation of a human colon cancer cell line. J Dairy Sci, 92, 2477-84 (2009)
15. Rodrigues, L., J. Teixeira, F. Schmitt, M. Paulsson & H. L. Mansson: Lactoferrin and cancer disease prevention. Crit Rev Food Sci Nutr, 49, 203-17 (2009)
16. Fischer, R., H. Debbabi, A. Blais, M. Dubarry, M. Rautureau, P. N. Boyaka & D. Tome: Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues. Int Immunopharmacol, 7, 1387-93 (2007) (Pubitemid 47161068)
17. Lonnerdal, B.: Nutritional roles of lactoferrin. Curr Opin Clin Nutr Metab Care, 12, 293-7 (2009)
18. Puddu, P., P. Valenti & S. Gessani: Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie, 91, 11-8 (2009)
19. Legrand, D., A. Pierce, E. Elass, M. Carpentier, C. Mariller & J. Mazurier: Lactoferrin structure and functions. Adv Exp Med Biol, 606, 163-94 (2008)
20. Kanwar, J. R., K. P. Palmano, X. Sun, R. K. Kanwar, R. Gupta, N. Haggarty, A. Rowan, S. Ram & G. W. Krissansen: 'Iron-saturated' lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy. Immunol Cell Biol, 86, 277-88 (2008) (Pubitemid 351430811)
21. Fujita, K., E. Matsuda, K. Sekine, M. Iigo & H. Tsuda: Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats. Carcinogenesis, 25, 1961-6 (2004) (Pubitemid 39405916)
22. Spagnuolo, P. A., R. P. Bird & L. Hoffman-Goetz: Effect of short-term dietary intake of bovine lactoferrin on intestinal lymphocyte apoptosis in healthy mice. Nutrition, 23, 812-7 (2007) (Pubitemid 47532390)
23. Shimamura, M., Y. Yamamoto, H. Ashino, T. Oikawa, T. Hazato, H. Tsuda & M. Iigo: Bovine lactoferrin inhibits tumor-induced angiogenesis. Int J Cancer, 111, 111-6 (2004) (Pubitemid 38859291)
24. Dinayadura, R.: To study the apoptotic pathways activated by Selenium saturated bovine lactoferrin (SebLF) treatment for colon cancer. School of Life and Environmental Sciences, Deakin University, 93 (2009)
25. AIHW: Breast cancer in Australia: an overview, 2009. Cancer Series, Australian Institute of Health and Welfare and National Breast and Ovarian Cancer Centre, 170 (2009)
26. W.H.O.: Cancer. Media Centre, 297 ed., World Health Organization (2009)
27. Jemal, A., R. Siegel, E. Ward, Y. Hao, J. Xu & M. J. Thun: Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49 (2009)
28. Kozu, T., G. Iinuma, Y. Ohashi, Y. Saito, T. Akasu, D. Saito, D. B. Alexander, M. Iigo, T. Kakizoe & H. Tsuda: Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial. Cancer Prev Res (Phila Pa), 2, 975-83 (2009)
29. Wolf, J. S., G. Li, A. Varadhachary, K. Petrak, M. Schneyer, D. Li, J. Ongkasuwan, X. Zhang, R. J. Taylor, S. E. Strome & B. W. O'Malley, Jr.: Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo. Clin Cancer Res, 13, 1601-10 (20 07) (Pubitemid 46450453)
30. Yamada, Y., R. Sato, S. Kobayashi, C. Hankanga, O. Inanami, M. Kuwabara, Y. Momota, N. Tomizawa & J. Yasuda: The antiproliferative effect of bovine lactoferrin on canine mammary gland tumor cells. J Vet Med Sci, 70, 443-8 (2008) (Pubitemid 351798924)
31. Sekine, K., E. Watanabe, J. Nakamura, N. Takasuka, D. J. Kim, M. Asamoto, V. Krutovskikh, H. Baba-Toriyama, T. Ota, M. A. Moore, M. Masuda, H. Sugimoto, H. Nishino, T. Kakizoe & H. Tsuda: Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn J Cancer Res, 88, 523-6 (1997) (Pubitemid 27348486)
32. Tsuda, H., K. Sekine, J. Nakamura, Y. Ushida, T. Kuhara, N. Takasuka, D. J. Kim, M. Asamoto, H. Baba-Toriyama, M. A. Moore, H. Nishino & T. Kakizoe: Inhibition of azoxymethane initiated colon tumor and aberrant crypt foci development by bovine lactoferrin administration in F344 rats. Adv Exp Med Biol, 443, 273-84 (1998) (Pubitemid 28432197)
33. Ushida, Y., K. Sekine, T. Kuhara, N. Takasuka, M. Iigo & H. Tsuda: Inhibitory effects of bovine lactoferrin on intestinal polyposis in the Apc (Min) mouse. Cancer Lett, 134, 141-5 (1998) (Pubitemid 29070730)
34. Tsuda, H., K. Sekine, Y. Ushida, T. Kuhara, N. Takasuka, M. Iigo, B. S. Han & M. A. Moore: Milk and dairy products in cancer prevention: focus on bovine lactoferrin. Mutat Res, 462, 227-33 (2000) (Pubitemid 30190230)
35. Tsuda, H., K. Sekine, N. Takasuka, H. Toriyama-Baba & M. Iigo: Prevention of colon carcinogenesis and carcinoma metastasis by orally administered bovine lactoferrin in animals. Biofactors, 12, 83-8 (2000) (Pubitemid 32107389)
36. Fujita, K., E. Matsuda, K. Sekine, M. Iigo & H. Tsuda: Lactoferrin modifies apoptosis-related gene expression in the colon of the azoxymethane-treated rat. Cancer Lett, 213, 21-9 (2004) (Pubitemid 39118530)
37. Tsuda, H., K. Sekine, K. Fujita & M. Ligo: Cancer prevention by bovine lactoferrin and underlying mechanisms - a review of experimental and clinical studies. Biochem Cell Biol, 80, 131-6 (2002) (Pubitemid 34194239)
38. Smalley, K. S., M. Lioni & M. Herlyn: Life isn't flat: taking cancer biology to the next dimension. In vitro Cell Dev Biol Anim, 42, 242-7 (2006) (Pubitemid 44851881)
39. Yamada, K. M. & E. Cukierman: Modeling tissue morphogenesis and cancer in 3D. Cell, 130, 601-10 (2007) (Pubitemid 47268064)
40. Serebriiskii, I., R. Castello-Cros, A. Lamb, E. A. Golemis & E. Cukierman: Fibroblast -derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells. Matrix Biol, 27, 573-85 (2008)
41. Kim, J. B., R. Stein & M. J. O'Hare: Three-dimensional in vitro tissue culture models of breast cancer - a review. Breast Cancer Res Treat, 85, 281-91 (2004) (Pubitemid 38987263)
42. Sodunke, T. R., K. K. Turner, S. A. Caldwell, K. W. McBride, M. J. Reginato & H. M. Noh: Micropatterns of Matrigel for three-dimensional epithelial cultures. Biomaterials, 28, 4006-16 (2007) (Pubitemid 47048369)
43. Hebner, C., V. M. Weaver & J. Debnath: Modeling morphogenesis and oncogenesis in three-dimensional breast epithelial cultures. Annu Rev Pathol, 3, 313-39 (2008) (Pubitemid 351488284)
44. Abu-Yousif, A. O., I. Rizvi, C. L. Evans, J. P. Celli & T. Hasan: PuraMatrix encapsulation of cancer cells. J Vis Exp (2009)
45. Li, Q., A. B. Chow & R. R. Mattingly: Threedimensional overlay culture models of human breast cancer reveal a critical sensitivity to mitogen-activated protein kinase kinase inhibitors. J Pharmacol Exp Ther, 332, 821-8 (2010)
46. Liu, H., D. C. Radisky & M. J. Bissell: Proliferation and polarity in breast cancer: untying the Gordian knot. Cell Cycle, 4, 646-9 (2005) (Pubitemid 41353842)
47. Iigo, M., T. Kuhara, Y. Ushida, K. Sekine, M. A. Moore & H. Tsuda: Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis, 17, 35-40 (1999) (Pubitemid 29284562)
48. Ushida, Y., K. Sekine, T. Kuhara, N. Takasuka, M. Iigo, M. Maeda & H. Tsuda: Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis in the rat. Jpn J Cancer Res, 90, 262-7 (1999) (Pubitemid 29164014)
49. Masuda, C., H. Wanibuchi, K. Sekine, Y. Yano, S. Otani, T. Kishimoto, H. Tsuda & S. Fukushima: Chemopreventiveeffects of bovine lactoferrin on N-butyl- N- (4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis. Jpn J Cancer Res, 91, 582-8 (2000) (Pubitemid 30453784)
50. Fischbach C, Kong HJ, Hsiong SX, Evangelista MB, Yuen W, Mooney DJ. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci U S A. 106 (2), 399-404. (2009)